Skip to main content
. 2017 Oct 11;56(23):3199–3204. doi: 10.2169/internalmedicine.8932-17

Figure 2.

Figure 2.

Abdominal early-phase (a) and delayed-phase contrast-enhanced (b) computed tomography images showing no obviously abnormal findings. (c) T2-weighted magnetic resonance imaging showing a moderate-signal-intensity pancreatic tumor (shown with arrow).